TLIS logo

Talis Biomedical (TLIS) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

12 February 2021

Indexes:

Not included

Description:

Talis Biomedical is a biotechnology company focused on developing rapid diagnostic tests for infectious diseases. Their innovative technology aims to provide quick and accurate results, helping healthcare providers make timely decisions. Talis is dedicated to improving patient care through advanced testing solutions.

Key Details

Price

$1.80

Annual Revenue

$412.00 K(-88.72% YoY)

Annual EPS

-$34.12(+45.64% YoY)

Annual ROE

-63.32%

Beta

0.75

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 28, 2024

Recent annual earnings:

Mar 22, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

July 06, 2023

Analyst ratings

Recent major analysts updates

16 Aug '23 BTIG
Sell
18 Mar '22 BTIG
Sell
16 Mar '22 B of A Securities
Underperform
07 Jan '22 B of A Securities
Underperform
27 Sept '21 JP Morgan
Underweight
12 Aug '21 Piper Sandler
Neutral
11 Aug '21 JP Morgan
Neutral
09 Mar '21 Piper Sandler
Overweight
09 Mar '21 JP Morgan
Overweight
09 Mar '21 BTIG
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Talis Biomedical Corporation (TLIS) Q1 2023 Earnings Call Transcript
Talis Biomedical Corporation (TLIS) Q1 2023 Earnings Call Transcript
Talis Biomedical Corporation (TLIS) Q1 2023 Earnings Call Transcript
TLIS
Seeking Alpha14 May 2023

Talis Biomedical Corporation (NASDAQ:TLIS ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Emily Faucette - Senior Vice President, Corporate Communications & Investor Relations Rob Kelley - Chief Executive Officer Becky Markovich - Interim Chief Financial Officer Conference Call Participants Mark Massaro - BTIG Operator Good day and thank you for standing by. Welcome to the Talis Biomedical's Business Update Conference Call.

FAQ

  • What is the primary business of Talis Biomedical?
  • What is the ticker symbol for Talis Biomedical?
  • Does Talis Biomedical pay dividends?
  • What sector is Talis Biomedical in?
  • What industry is Talis Biomedical in?
  • What country is Talis Biomedical based in?
  • When did Talis Biomedical go public?
  • Is Talis Biomedical in the S&P 500?
  • Is Talis Biomedical in the NASDAQ 100?
  • Is Talis Biomedical in the Dow Jones?
  • When was Talis Biomedical's last earnings report?
  • When does Talis Biomedical report earnings?
  • Should I buy Talis Biomedical stock now?

What is the primary business of Talis Biomedical?

Talis Biomedical is a biotechnology company focused on developing rapid diagnostic tests for infectious diseases. Their innovative technology aims to provide quick and accurate results, helping healthcare providers make timely decisions. Talis is dedicated to improving patient care through advanced testing solutions.

What is the ticker symbol for Talis Biomedical?

The ticker symbol for Talis Biomedical is NASDAQ:TLIS

Does Talis Biomedical pay dividends?

No, Talis Biomedical does not pay dividends

What sector is Talis Biomedical in?

Talis Biomedical is in the Healthcare sector

What industry is Talis Biomedical in?

Talis Biomedical is in the Medical Devices industry

What country is Talis Biomedical based in?

Talis Biomedical is headquartered in United States

When did Talis Biomedical go public?

Talis Biomedical's initial public offering (IPO) was on 12 February 2021

Is Talis Biomedical in the S&P 500?

No, Talis Biomedical is not included in the S&P 500 index

Is Talis Biomedical in the NASDAQ 100?

No, Talis Biomedical is not included in the NASDAQ 100 index

Is Talis Biomedical in the Dow Jones?

No, Talis Biomedical is not included in the Dow Jones index

When was Talis Biomedical's last earnings report?

Talis Biomedical's most recent earnings report was on 28 November 2024

When does Talis Biomedical report earnings?

The date for Talis Biomedical's next earnings report has not been announced yet

Should I buy Talis Biomedical stock now?

As of today, analysts generally recommend a 'Strong sell' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions